Department of Psychiatry
Penn Behavioral Health

Center for Studies of Addiction

subpage feature

Brain-Behavioral Vulnerabilities Laboratory

 

CURE studies have ended recruitment as of 9/30/14

 

 

CURE Cocaine, Marijuana, and Opiates

 

COCAINE STUDY

C.U.R.E Addiction Center of Excellence
Brain Mechanisms of Relapse and Recovery 

Funded by the Commonwealth of Pennsylvania Universal Research Enhancement  (C.U.R.E.)


About

The C.U.R.E Center is a large-scale study of the brain and behavioral factors that underlie addiction. The goal of the study is to find objective indicators of vulnerability to addiction and predictors of relapse and recovery.


Do you or someone you know suffer from cocaine dependence?

C.U.R.E. and the University of Pennsylvania’s Center for the Study of Addictions is currently conducting a research study in which participants are offered a 7-10 day inpatient stay followed by weekly outpatient drug counseling and psychosocial treatment for 12 weeks.  Participation in this study also includes up to 4 fMRI scans that occur before, during, and after the treatment period.


If you or someone you know are interested, call:

Toll free: 1-800-528-5527
In PA: 215-222-3200 ext. 176
-or-
Email: marquezk@mail.med.upenn.edu (Kathleen Marquez) for additional information


Click on a link below for additional information:

 


 

MARIJUANA STUDY

C.U.R.E Addiction Center of Excellence
Brain Mechanisms of Relapse and Recovery 

Funded by the Commonwealth of Pennsylvania Universal Research Enhancement  (C.U.R.E.)


About

The C.U.R.E Center is a large-scale study of the brain and behavioral factors that underlie addiction. The goal of the study is to find objective indicators of vulnerability to addiction and predictors of relapse and recovery.


Do you or someone you know suffer from marijuana dependence?

C.U.R.E. and the University of Pennsylvania’s Center for the Study of Addictions is currently conducting a research study in which participants receive Baclofen, an FDA-approved medication, or placebo, an inactive medication, that may help prevent or reduce craving for marijuana.  Participation in this study also includes weekly outpatient drug counseling and psychosocial treatment, and up to 4 fMRI scans that occur before, during, and after the 12 week treatment period.


If you or someone you know are interested, call:

Toll free: 1-800-528-5527
In PA: 215-222-3200 ext. 188
-or-
Email: marquezk@mail.med.upenn.edu (Kathleen Marquez) for additional information


Click on a link below for additional information:

 


 

OPIATE STUDY

C.U.R.E Addiction Center of Excellence
Brain Mechanisms of Relapse and Recovery 

Funded by the Commonwealth of Pennsylvania Universal Research Enhancement  (C.U.R.E.)


About

The C.U.R.E Center is a large-scale study of the brain and behavioral factors that underlie addiction. The goal of the study is to find objective indicators of vulnerability to addiction and predictors of relapse and recovery.


Do you or someone you know suffer from opiate dependence?

C.U.R.E. and the University of Pennsylvania’s Center for the Study of Addictions is conducting a study in which participants receive a monthly injection of long acting opiate blocker naltrexone (Vivitrol ®) over the course of 3 months, at no cost to you.  Vivitrol is an FDA approved non-narcotic treatment of opiate dependence. Participants in this study also receive FREE weekly outpatient counseling and therapy, and up to 4 fMRI scans that occur before, during, and after the 12 week treatment period.


If you or someone you know are interested, call:

Toll free: 1-800-528-5527
In PA: 215-222-3200 ext. 172
-or-
Email: marquezk@mail.med.upenn.edu (Kathleen Marquez) for additional information


Click on a link below for additional information:





< back to BBV Clinical Trials page